Simulation modeling of change to breast cancer detection age eligibility recommendations in Ontario, 2002-2021.

PURPOSE The purpose of this project was to demonstrate the development and use of a decision support tool based on simulation modeling of breast cancer screening to evaluate the implications for the provision of health services and the economic impact of extending routine radiographic screening for breast cancer to women in the 40-49 age group between 2002 and 2021. METHODS The main method was computer simulation with a Markov model that used published estimates of population size by age group, breast cancer prevalence and incidence, screening program participation rate, sensitivity and specificity of the screening test and diagnostic test, stage transition probabilities, directed diagnosis rates and costs. FINDINGS The model predicted that changes to age eligibility requirements would result in the detection of an additional 6610 women with breast cancer in Ontario requiring treatment, at an additional cost of 795 Canadian per case. These costs include those related to screening, diagnosis and initial treatment and apply to the 20-year period. CONCLUSIONS The model provided a useful decision support tool for those planning and implementing breast cancer screening programs.

[1]  B. Vicandi,et al.  Fine Needle Aspiration Cytology of Breast Fibroadenoma , 1999, Acta Cytologica.

[2]  R. Hendrick,et al.  Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. , 1997, Journal of the National Cancer Institute. Monographs.

[3]  David Haber,et al.  Guide to clinical preventive services: a challenge to physician resourcefulness , 1993 .

[4]  P. Thorner,et al.  Effectiveness of fine‐needle aspiration cytology of breast: Analysis of 2,375 cases from northern Thailand , 2002, Diagnostic cytopathology.

[5]  C. Baines.  Mammography screening: are women really giving informed consent? , 2003, Journal of the National Cancer Institute.

[6]  Peter C Gøtzsche,et al.  Cochrane review on screening for breast cancer with mammography , 2001, The Lancet.

[7]  P. Bravetti,et al.  Solid nonpalpable breast lesions , 1997, Acta radiologica.

[8]  Accuracy of fine needle aspiration biopsy of the breast. , 1997, Biomedical sciences instrumentation.

[9]  TNM: CLASSIFICATION OF MALIGNANT TUMOURS , 1969 .

[10]  Jennifer Zelmer,et al.  Health Care in Canada 2003 , 2003 .

[11]  J. Berthelot,et al.  Estimates of the lifetime costs of breast cancer treatment in Canada. , 2000, European journal of cancer.

[12]  K. Suen,et al.  Cancer and old age. An autopsy study of 3,535 patients over 65 years old , 1974, Cancer.

[13]  S Shapiro,et al.  Report of the International Workshop on Screening for Breast Cancer. , 1993, Journal of the National Cancer Institute.

[14]  D. Bragg,et al.  Selective use of image-guided large-core needle biopsy of the breast: accuracy and cost-effectiveness. , 1995, AJR. American journal of roentgenology.

[15]  A. Feinstein,et al.  Incidence, prevalence, and evidence. Scientific problems in epidemiologic statistics for the occurrence of cancer. , 1987, The American journal of medicine.

[16]  Ingvar Andersson,et al.  Long-term effects of mammography screening: updated overview of the Swedish randomised trials , 2002, The Lancet.

[17]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[18]  H. D. de Koning,et al.  Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study , 1998, BMJ.

[19]  S. Wilson.  Methods for the economic evaluation of health care programmes , 1987 .

[20]  T. To,et al.  The Canadian National Breast Screening Study-1: Breast Cancer Mortality after 11 to 16 Years of Follow-up: A Randomized Screening Trial of Mammography in Women Age 40 to 49 Years , 2002, Annals of Internal Medicine.

[21]  J. Habbema,et al.  A model‐based analysis of the hip project for breast cancer screening , 1990, International journal of cancer.

[22]  C A Kelsey,et al.  Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico. , 1998, Radiology.

[23]  J. Habbema,et al.  The cost‐effectiveness of breast cancer screening , 1989, International journal of cancer.

[24]  S K Plevritis,et al.  A mathematical algorithm that computes breast cancer sizes and doubling times detected by screening. , 2001, Mathematical biosciences.

[25]  J. Riera,et al.  Fine Needle Aspiration of Breast Masses , 1997 .

[26]  Graham A. Colditz,et al.  Cost-effectiveness of screening for colorectal cancer in the general population. , 2000, JAMA.

[27]  J. Ringash.  Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.